O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and Low MGMT-Encoded Protein Expression as Prognostic Markers in Glioblastoma Patients Treated with Biodegradable Carmustine Wafer Implants after Initial Surgery Followed by Radiotherapy with Concomitant and Adjuvant Temozolomide

Js Guillamo (1) , G Levallet (1) , A Dugué (1) , A Vital (1) , Md Diebold (1) , P Menei (1) , P Colin (1) , P Peruzzy (1) , E Emery (1) , M Bernaudin (2) , F Chapon (1) , E Lechapt-Zalcman (2)

1 CHU Caen
2 CERVOxy - Hypoxie, physiopathologies cérébrovasculaire et tumorale

Domains: Life Sciences [q-bio]

Js Guillamo, G Levallet, A Dugué, A Vital, Md Diebold, et al.. O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and Low MGMT-Encoded Protein Expression as Prognostic Markers in Glioblastoma Patients Treated with Biodegradable Carmustine Wafer Implants after Initial Surgery Followed by Radiotherapy with Concomitant and Adjuvant Temozolomide. 64th Annual Meeting of the American-Academy-of-Neurology (AAN), Apr 2012, New Orleans, United States. pp.P06.004. ⟨hal-02265457⟩